{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:52:34Z","timestamp":1781149954128,"version":"3.54.1"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas GeraisFunda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais (FAPEMIG)","award":["APQ-02064-15"],"award-info":[{"award-number":["APQ-02064-15"]}]},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gicoConselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["406122\/2016-4"],"award-info":[{"award-number":["406122\/2016-4"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.neuropharm.2019.01.022","type":"journal-article","created":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T01:33:34Z","timestamp":1548034414000},"page":"284-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks"],"prefix":"10.1016","volume":"148","author":[{"given":"Th\u00e9rcia G.","family":"Viana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana R.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayssa B.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Hott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico S.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e2ndido C.","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo B.","family":"Resstel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele C.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabr\u00edcio A.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.01.022_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbr.2013.05.027","article-title":"Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray","volume":"252","author":"Almeida-Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/FBP.0000000000000073","article-title":"Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs","volume":"25","author":"Batista","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib3","first-page":"CD011567","article-title":"Antidepressants and benzodiazepines for panic disorder in adults","volume":"9","author":"Bighelli","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.biopsych.2011.04.022","article-title":"Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses","volume":"70","author":"Busquets-Garcia","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0091-3057(01)00685-2","article-title":"The medial hypothalamic defensive system: hodological organization and functional implications","volume":"71","author":"Canteras","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0361-9230(97)00141-X","article-title":"Severe reduction of rat defensive behavior to a predator by discrete hypothalamic chemical lesions","volume":"44","author":"Canteras","year":"1997","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neubiorev.2014.03.020","article-title":"Executive and modulatory neural circuits of defensive reactions: implications for panic disorder","volume":"46 Pt 3","author":"Canteras","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib8","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/npp.2011.207","article-title":"Opposing roles for cannabinoid receptor type-1 (CB(1)) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats","volume":"37","author":"Casarotto","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pnpbp.2016.02.001","article-title":"Treatment-resistant panic disorder: clinical significance, concept and management","volume":"70","author":"Chen","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib10","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1016\/S0140-6736(16)30381-6","article-title":"Anxiety","volume":"388","author":"Craske","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib11","doi-asserted-by":"crossref","first-page":"17024","DOI":"10.1038\/nrdp.2017.24","article-title":"Anxiety disorders","volume":"3","author":"Craske","year":"2017","journal-title":"Nat. Rev. Dis. Prime"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/384083a0","article-title":"Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides","volume":"384","author":"Cravatt","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neuroscience.2005.12.041","article-title":"Excitatory amino acid receptors in the periaqueductal gray mediate the cardiovascular response evoked by activation of dorsomedial hypothalamic neurons","volume":"139","author":"da Silva","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/0269881109103800","article-title":"Anxiety--bridging the heart\/mind divide","volume":"24","author":"Davies","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1177\/0269881113492900","article-title":"5-HT1A and 5-HT2A receptor control of a panic-like defensive response in the rat dorsomedial hypothalamic nucleus","volume":"27","author":"de Bortoli","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.psyneuen.2014.12.022","article-title":"In a rat model of panic, corticotropin responses to dorsal periaqueductal gray stimulation depend on physical exertion","volume":"53","author":"de Souza Armini","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib17","first-page":"605","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib18","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0006-8993(01)02227-2","article-title":"The cardiovascular and behavioral response to cat odor in rats: unconditioned and conditioned effects","volume":"897","author":"Dielenberg","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib20","doi-asserted-by":"crossref","first-page":"10819","DOI":"10.1073\/pnas.152334899","article-title":"Brain monoglyceride lipase participating in endocannabinoid inactivation","volume":"99","author":"Dinh","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib21","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/sj.npp.1301168","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder","volume":"31","author":"Erhardt","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib22","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1210\/en.2010-0285","article-title":"Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling","volume":"151","author":"Evanson","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0028-3908(03)00235-1","article-title":"Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats","volume":"45","author":"Finn","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.psychres.2004.04.010","article-title":"Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking","volume":"133","author":"Garcia-Leal","year":"2005","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.euroneuro.2015.11.014","article-title":"Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey","volume":"26","author":"Gobira","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neubiorev.2016.10.013","article-title":"Translational approach to the pathophysiology of panic disorder: focus on serotonin and endogenous opioids","volume":"76","author":"Graeff","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0001-37652005000300009","article-title":"Does the panic attack activate the hypothalamic-pituitary-adrenal axis?","volume":"77","author":"Graeff","year":"2005","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib28","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1523\/JNEUROSCI.0013-12.2012","article-title":"Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-alpha initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia","volume":"32","author":"Gregg","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery","volume":"12","author":"Griebel","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(97)01336-8","article-title":"Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals","volume":"339","author":"Griffin","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib31","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrn3301","article-title":"The many paths to fear","volume":"13","author":"Gross","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib32","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib33","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cphy.c150015","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib35","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0914661107","article-title":"Endogenous cannabinoid signaling is essential for stress adaptation","volume":"107","author":"Hill","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib36","doi-asserted-by":"crossref","first-page":"14980","DOI":"10.1523\/JNEUROSCI.4283-10.2010","article-title":"Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output","volume":"30","author":"Hill","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuroscience.2011.12.030","article-title":"Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis","volume":"204","author":"Hill","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib38","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/nature03658","article-title":"An endocannabinoid mechanism for stress-induced analgesia","volume":"435","author":"Hohmann","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.neubiorev.2014.07.027","article-title":"Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks","volume":"46 Pt 3","author":"Johnson","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib40","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.physbeh.2012.03.016","article-title":"An animal model of panic vulnerability with chronic disinhibition of the dorsomedial\/perifornical hypothalamus","volume":"107","author":"Johnson","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib42","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1017\/S1461145710000684","article-title":"Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning","volume":"13","author":"Lisboa","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib43","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1017\/S1461145712000569","article-title":"Hyperactivity induced by the dopamine D2\/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice","volume":"16","author":"Luque-Rojas","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib44","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(87)90005-0","article-title":"GABA-benzodiazepine modulation of aversion in the medial hypothalamus of the rat","volume":"28","author":"Milani","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib48","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.neuropharm.2006.10.013","article-title":"Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray","volume":"52","author":"Moreira","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00441-013-1610-1","article-title":"Modeling panic disorder in rodents","volume":"354","author":"Moreira","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib51","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.neuro.2008.08.001","article-title":"Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate","volume":"29","author":"Nallapaneni","year":"2008","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1092852900009901","article-title":"Overview of diagnosis and drug treatments of anxiety disorders","volume":"10","author":"Nutt","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity","volume":"26","author":"Onaivi","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib55","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1111\/j.1460-9568.2008.06266.x","article-title":"Adaptations in endocannabinoid signaling in response to repeated homotypic stress: a novel mechanism for stress habituation","volume":"27","author":"Patel","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib56","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1210\/en.2004-0638","article-title":"Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"145","author":"Patel","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib71","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib57","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB(1) and CB(2)","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00213-008-1156-1","article-title":"Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats","volume":"198","author":"Resstel","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib59","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2007.06.024","article-title":"CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour","volume":"54","author":"Rubino","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib60","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.phrs.2011.04.010","article-title":"Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats","volume":"64","author":"Sciolino","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib61","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/0006-3223(94)90086-8","article-title":"Effects of treatment with imipramine and clonazepam on an animal model of panic disorder","volume":"36","author":"Shekhar","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib62","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0006-8993(94)01451-M","article-title":"c-fos immunoreactivity in the brain following electrical or chemical stimulation of the medial hypothalamus of freely moving rats","volume":"674","author":"Silveira","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-3223(02)01574-3","article-title":"Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs","volume":"53","author":"Singewald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib64","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-1781(99)00029-3","article-title":"Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation","volume":"86","author":"Sinha","year":"1999","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib65","first-page":"R13","article-title":"GABAA and excitatory amino acid receptors in dorsomedial hypothalamus and heart rate in rats","volume":"260","author":"Soltis","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib66","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00213-014-3793-x","article-title":"Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats","volume":"232","author":"Viana","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2019.01.022_bib67","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1523\/JNEUROSCI.1046-10.2010","article-title":"Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus","volume":"30","author":"Wamsteeker","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib68","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3171\/2009.9.JNS09577","article-title":"Induction of panic attack by stimulation of the ventromedial hypothalamus","volume":"112","author":"Wilent","year":"2010","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/cn300036b","article-title":"Characterization of the effects of reuptake and hydrolysis inhibition on interstitial endocannabinoid levels in the brain: an in vivo microdialysis study","volume":"3","author":"Wiskerke","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.01.022_bib70","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat. Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819300231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819300231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T19:49:43Z","timestamp":1606074583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819300231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":71,"alternative-id":["S0028390819300231"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.01.022","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}